Oncosem has achieved significant success in health technologies in England.

The Turkish health technology sector has achieved significant success internationally. Oncosem, through its wholly-owned subsidiary Oncosem UK Ltd. based in London, has drawn attention by winning a prestigious tender opened by the National Health Service (NHS) in England.

This tender was conducted under the project known as Needle-Free Connection Systems and Associated Products 2025. With its bid for this important tender, Oncosem has been certified as a successful supplier for a total of 97 different product items. In the company's statement, it was emphasized that they achieved positive results for all 97 items offered with their IVEIN brand, produced at a 95% domestic production rate and holding a 70% market share in Turkey.

Oncosem's success is quite significant for both the company and the international competitive power of the Turkish healthcare sector. Being selected as the sole supplier for 19 items, one of two suppliers for 14 items, and one of three suppliers for 20 items in the NHS tender has strengthened the company's strong position in the sector. This situation once again highlights Turkey's innovation capacity in healthcare technologies.

With its entry into the UK market, the company aims to reach a broader customer and market potential. Deliveries of the products are scheduled for this November. This success not only increases Oncosem's global recognition but also strengthens the competitive power of the Turkish health technology sector worldwide.

Oncosem's success in this tender also demonstrates how effective policies supporting domestic production can be in international markets. With such various projects, more Turkish companies are expected to take a larger place in the global arena.